In the BioHarmony Drug Report Database

"Preview" Icon

Streptozocin

Zanosar (streptozocin) is a small molecule pharmaceutical. Streptozocin was first approved as Zanosar on 1982-05-07. It is used to treat colorectal neoplasms, hodgkin disease, and islet cell carcinoma in the USA.

 

Trade Name

 

Zanosar
 

Common Name

 

streptozocin
 

ChEMBL ID

 

CHEMBL1651906
 

Indication

 

colorectal neoplasms, hodgkin disease, islet cell carcinoma
 

Drug Class

 

Image (chem structure or protein)

Streptozocin structure rendering